ELIZABETH WARNICK: Open Payments
NPI 1578524542 · NATRONA HEIGHTS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,425 in 115 payments from 34 companies in 2025. Trend: 2023 $1,179 · 2024 $2,046 · 2025 $2,425
Food & beverage: $2,256Education: $169
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 22 | $364 |
| AstraZeneca Pharmaceuticals LP | 11 | $232 |
| Novartis Pharmaceuticals Corporation | 10 | $210 |
| Incyte Corporation | 7 | $165 |
| Janssen Biotech, Inc. | 9 | $146 |
| Ipsen Biopharmaceuticals, Inc | 3 | $128 |
| Merck Sharp & Dohme LLC | 5 | $123 |
| Lilly USA, LLC | 4 | $95 |
| PFIZER INC. | 5 | $85 |
| Aveo Pharmaceuticals, Inc. | 1 | $83 |
Products named: Enhertu, KEYTRUDA, RYBREVANT, INJECTAFER, VERZENIO, CALQUENCE, FOTIVDA, JAKAFI.
Industry payments across PA — which companies pay providers there.
